Ying Min Wang
Direttore/Membro del Consiglio presso Sunbird Bio, Inc.
Profilo
Ying Min Wang currently works at Clavystbio Pte Ltd., as Director from 2022 and Sunbird Bio, Inc., as Director from 2023.
Posizioni attive di Ying Min Wang
| Società | Posizione | Inizio |
|---|---|---|
Clavystbio Pte Ltd.
 Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio Pte Ltd (Clavystbio) is a venture capital subsidiary of CLA Real Estate Holdings Pte Ltd founded in 2022. The firm is headquartered in Singapore. | Investitore di Private Equity | 01/01/2022 |
Sunbird Bio, Inc.
 Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | Direttore/Membro del Consiglio | 01/05/2023 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Clavystbio Pte Ltd.
Clavystbio Pte Ltd. Investment ManagersFinance Clavystbio Pte Ltd (Clavystbio) is a venture capital subsidiary of CLA Real Estate Holdings Pte Ltd founded in 2022. The firm is headquartered in Singapore. | Finance |
Sunbird Bio, Inc.
Sunbird Bio, Inc. BiotechnologyHealth Technology Sunbird Bio, Inc. is a biotech company based in Cambridge, MA. Sunbird Bio is developing protein-based diagnostic tests to empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer. The private company's apex technology is the first test to demonstrate the ability to detect the presence of Alzheimer's disease with a blood test. Sunbird Bio is addressing diagnostic testing to enhance patient care. The company was founded by Nicholas Ho, Carine Lim, and Huilin Shao. The CEO is John P. McDonough. | Health Technology |
- Borsa valori
- Insiders
- Ying Min Wang
